NCT06699407View on ClinicalTrials.gov

Qishenyiqi for Ventricular Remodeling After Myocardial Infarction

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Chronic Stable Heart Failure
Interventions
DRUG

Qishenyiqi dripping pills

Qishenyiqi dripping pills, 1 bag once, three times a day, 12 months

DRUG

Placebo

Placebo, 1 bag once, three times a day, 12 months

Trial Locations (3)

250012

Panpan Hao, Jinan

Qianfoshan Hospital, Shandong University, Jinan

Unknown

Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan

All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER

NCT06699407 - Qishenyiqi for Ventricular Remodeling After Myocardial Infarction | Biotech Hunter | Biotech Hunter